Coronavirus: Chinese COVID-19 vaccine enters third-stage human trial


Key Topics in this News Article:

News Snapshot:

COVID-19 vaccine: India could get access to AstraZeneca vaccine by January, says local manufacturer Jointly developed by the company and the Institute of Microbiology under the Chinese Academy of Sciences, the vaccine was issued a clinical research permit from the National Medical Products Administration on June 19. The company said the research, which plans to enroll up to 29,000 adults aged 18 and up, was launched on Wednesday in Xiangtan County, central China’s Hunan Province. Global trials are expected to begin in Uzbekistan late this month, followed by trials in Indonesia, Pakistan and Ecuador. A Chinese Foreign Ministry spokesman Zhao...